2nd Quarter - Report

INNOVATIVE FEDERAL STRATEGIES, LLC for CERUS CORPORATION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

HR.2810/S.___, National Defense Authorization Act, 2018, any title, all provisions relating to blood products.

LobbyistCovered position, as disclosed
CARL KIME —
KALI MATALON —
NEELY MARCUS SILBEY New —
ANNE MARGARET WAKE New —
LETITIA WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Bills named: H.R. 2810 (115th)

Health Issues HCR

Submitted outside witness testimony on Biomedical Advanced Research and Development Authority.

LobbyistCovered position, as disclosed
CARL KIME —
KALI MATALON —
NEELY MARCUS SILBEY New —
ANNE MARGARET WAKE New —
LETITIA WHITE —

Contacted: Veterans Affairs, Dept of (VA); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to blood products, Title VI, all provisions related to blood products and technologies. H.R.___/S.___, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018, Title II, all provisions related to blood products. H.R___/S/___, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018, Title II, all provisions relating to blood products.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
CARL KIME —
KALI MATALON —
NEELY MARCUS SILBEY New —
ANNE MARGARET WAKE New —
LETITIA WHITE —

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.